Increased risk of adverse drug reactions by higher linezolid dose per weight in multidrug-resistant tuberculosis

Linezolid treatment has a high risk of toxicity and adverse drug reactions (ADR) are frequent. Few studies have investigated risk factors of major ADRs separately, therefore, we aimed to evaluate major ADRs including peripheral neuropathy in relation to risk factors and drug concentration levels of...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	International journal of antimicrobial agents Ročník 64; číslo 4; s. 107302
Hlavní autoři:	Kuhlin, Johanna, Davies Forsman, Lina, Osman, Aisha, Skagerberg, Magdalena, Jonsson, Jerker, Groenheit, Ramona, Mansjö, Mikael, Werngren, Jim, Alffenaar, Jan-Willem, Schön, Thomas, Bruchfeld, Judith
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	Netherlands Elsevier Ltd 01.10.2024
Témata:	adverse drug reactions Anaemia Drug concentrations Infectious Disease Leukopenia Linezolid MDR-TB Peripheral neuropathy Thrombocytopenia Linezolid Thrombocytopenia CTCAE MGIT Leukopenia Anaemia MIC MDR-TB HR Peripheral neuropathy ADR AUC adverse drug reactions Drug concentrations BMI WHO area under the concentration time-curve adverse drug reaction Common Terminology Criteria for Adverse Events World Health Organization body mass index multidrug-resistant tuberculosis minimum inhibitory concentration Mycobacterial Growth Indicator Tube hazard ratio leukopenia linezolid anaemia thrombocytopenia drug concentrations peripheral neuropathy
ISSN:	0924-8579, 1872-7913, 1872-7913
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Buďte první, kdo okomentuje tento záznam!